Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Hepatol Int. 2024 Apr;18(2):700-701.
doi: 10.1007/s12072-024-10664-8.
Epub 2024 Feb 29.
1 Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea.
2 Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea. puby17@naver.com.
3 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaruro Wonmigu, Bucheonsi, Gyeonggido, 14584, Republic of Korea. puby17@naver.com.